Global Clinical Microbiology
Global Clinical Microbiology

Clinical Microbiology Comprehensive Study by Application (Pharmaceutical, Food Testing, Energy, Chemical and Material Manufacturing, Environment), End Users (Hospital, Diagnolab, Academia), Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Other), Sample (Urine, Blood, Saliva, Others), Product (Instrument, Analyzer, Reagent) Players and Region - Global Market Outlook to 2025

Clinical Microbiology Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 236 Pages 166 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Clinical Microbiology Market?

Clinical Microbiology is becoming a crucial requirement from many industries including healthcare, food, consumer products, cosmetics and beauty products, medical devices, fuels, drinking water, and oil exploration, across the globe. It is concerned with the prevention, diagnosis, and treatment of infectious diseases. The constant changes in viruses such as influenza, HIV, tuberculosis, malaria, and SARS are a massive challenge to modern medicine and public health. The microbiology testing industry is going under several technological advancements that will help to reshape this field. The tools and instruments present in the microbiology laboratories are constantly developing intending to decrease the overall time taken to obtain the results, enhance ease of sample processing, and increase sample turnaround time. This field is moving exceptionally fast, in part because it can take full advantage of the new developments. According to the study, the global microbiology testing market reached around USD ~14,819.44 Million, FY2019. From which the major ratio is covered by North America, and followed by Europe and the Asia Pacific. Here the Asia Pacific accounts ~19% from the global market. In the Asia Pacific region, China and Japan are covering major market share. Here, China covered around ~27% of the total Asia Pacific market. The major trend in the China region is the rapid adoption of microbiology testing for blood cultures. Becton Dickinson and BioMerieux are dominant players in the Chinese market. In China, microbiology testing is also high adopted for TB diagnosis, because in China they are frequently looking drug-resistant for TB diagnosis.

The market study is being classified, by Application (Pharmaceutical, Food Testing, Energy, Chemical and Material Manufacturing and Environment) and major geographies with country level break-up.

3M (United States), Agilent Technologies Inc. (United States), Avantor (United States), Becton Dickinson (United States), Biomrieux SA (France), Bio-Rad Laboratories (United States), Danaher Corporation (United States), NEOGEN Corporation (United States), Merck (United States) and Thermo Fisher Scientific (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Hologic (United States), Bruker (United States) and Roche Diagnostics (Switzerland).

The market is seeing an increasing number of market players, by witnessing rapid growth in this market the market-leading players are strongly focusing on the production technologies, efficiency enhancement, and others. There is a various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and highly investing in research and development. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Microbiology market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Clinical Microbiology market by Type, Application and Region.

On the basis of geography, the market of Clinical Microbiology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Occurrence of Infectious Diseases
  • Growing Outbreaks of Epidemics

Market Trend
  • Collaboration and Tie Up of Leading Players

Restraints
  • Stringent Government Regulations

Opportunities
  • The Explosion of Real-Time PCR is creating the Microbiology Testing Market

Challenges
  • Limited Reimbursement Policies Hampers the Microbiology Testing Market


In 2019, bioMérieux announced the acquisition of Invisible Sentinel, a company engaged in the development of molecular diagnostic tools for the rapid, accurate, and reliable detection of pathogens. Through this initiative, the company aims to capture major market share in the market.


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Clinical Microbiology, Government Regulatory and Research Organizations and End-Use Industries

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Pharmaceutical
  • Food Testing
  • Energy
  • Chemical and Material Manufacturing
  • Environment
By End Users
  • Hospital
  • Diagnolab
  • Academia

By Disease
  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other

By Sample
  • Urine
  • Blood
  • Saliva
  • Others

By Product
  • Instrument
  • Analyzer
  • Reagent

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Occurrence of Infectious Diseases
      • 3.2.2. Growing Outbreaks of Epidemics
    • 3.3. Market Challenges
      • 3.3.1. Limited Reimbursement Policies Hampers the Microbiology Testing Market
    • 3.4. Market Trends
      • 3.4.1. Collaboration and Tie Up of Leading Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Microbiology, by Application, End Users, Disease, Sample, Product and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Clinical Microbiology (Value)
      • 5.2.1. Global Clinical Microbiology by: Application (Value)
        • 5.2.1.1. Pharmaceutical
        • 5.2.1.2. Food Testing
        • 5.2.1.3. Energy
        • 5.2.1.4. Chemical and Material Manufacturing
        • 5.2.1.5. Environment
      • 5.2.2. Global Clinical Microbiology by: End Users (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Diagnolab
        • 5.2.2.3. Academia
      • 5.2.3. Global Clinical Microbiology by: Disease (Value)
        • 5.2.3.1. Respiratory Diseases
        • 5.2.3.2. Bloodstream Infections
        • 5.2.3.3. Gastrointestinal Diseases
        • 5.2.3.4. Sexually Transmitted Diseases
        • 5.2.3.5. Urinary Tract Infections
        • 5.2.3.6. Periodontal Diseases
        • 5.2.3.7. Other
      • 5.2.4. Global Clinical Microbiology by: Sample (Value)
        • 5.2.4.1. Urine
        • 5.2.4.2. Blood
        • 5.2.4.3. Saliva
        • 5.2.4.4. Others
      • 5.2.5. Global Clinical Microbiology by: Product (Value)
        • 5.2.5.1. Instrument
        • 5.2.5.2. Analyzer
        • 5.2.5.3. Reagent
      • 5.2.6. Global Clinical Microbiology Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Clinical Microbiology (Price)
  • 6. Clinical Microbiology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Avantor (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton Dickinson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biomrieux SA (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NEOGEN Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Microbiology Sale, by Application, End Users, Disease, Sample, Product and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Clinical Microbiology (Value)
      • 7.2.1. Global Clinical Microbiology by: Application (Value)
        • 7.2.1.1. Pharmaceutical
        • 7.2.1.2. Food Testing
        • 7.2.1.3. Energy
        • 7.2.1.4. Chemical and Material Manufacturing
        • 7.2.1.5. Environment
      • 7.2.2. Global Clinical Microbiology by: End Users (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Diagnolab
        • 7.2.2.3. Academia
      • 7.2.3. Global Clinical Microbiology by: Disease (Value)
        • 7.2.3.1. Respiratory Diseases
        • 7.2.3.2. Bloodstream Infections
        • 7.2.3.3. Gastrointestinal Diseases
        • 7.2.3.4. Sexually Transmitted Diseases
        • 7.2.3.5. Urinary Tract Infections
        • 7.2.3.6. Periodontal Diseases
        • 7.2.3.7. Other
      • 7.2.4. Global Clinical Microbiology by: Sample (Value)
        • 7.2.4.1. Urine
        • 7.2.4.2. Blood
        • 7.2.4.3. Saliva
        • 7.2.4.4. Others
      • 7.2.5. Global Clinical Microbiology by: Product (Value)
        • 7.2.5.1. Instrument
        • 7.2.5.2. Analyzer
        • 7.2.5.3. Reagent
      • 7.2.6. Global Clinical Microbiology Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Clinical Microbiology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Microbiology: by Application(USD Million)
  • Table 2. Clinical Microbiology Pharmaceutical , by Region USD Million (2014-2019)
  • Table 3. Clinical Microbiology Food Testing , by Region USD Million (2014-2019)
  • Table 4. Clinical Microbiology Energy , by Region USD Million (2014-2019)
  • Table 5. Clinical Microbiology Chemical and Material Manufacturing , by Region USD Million (2014-2019)
  • Table 6. Clinical Microbiology Environment , by Region USD Million (2014-2019)
  • Table 7. Clinical Microbiology: by End Users(USD Million)
  • Table 8. Clinical Microbiology Hospital , by Region USD Million (2014-2019)
  • Table 9. Clinical Microbiology Diagnolab , by Region USD Million (2014-2019)
  • Table 10. Clinical Microbiology Academia , by Region USD Million (2014-2019)
  • Table 11. Clinical Microbiology: by Disease(USD Million)
  • Table 12. Clinical Microbiology Respiratory Diseases , by Region USD Million (2014-2019)
  • Table 13. Clinical Microbiology Bloodstream Infections , by Region USD Million (2014-2019)
  • Table 14. Clinical Microbiology Gastrointestinal Diseases , by Region USD Million (2014-2019)
  • Table 15. Clinical Microbiology Sexually Transmitted Diseases , by Region USD Million (2014-2019)
  • Table 16. Clinical Microbiology Urinary Tract Infections , by Region USD Million (2014-2019)
  • Table 17. Clinical Microbiology Periodontal Diseases , by Region USD Million (2014-2019)
  • Table 18. Clinical Microbiology Other , by Region USD Million (2014-2019)
  • Table 19. Clinical Microbiology: by Sample(USD Million)
  • Table 20. Clinical Microbiology Urine , by Region USD Million (2014-2019)
  • Table 21. Clinical Microbiology Blood , by Region USD Million (2014-2019)
  • Table 22. Clinical Microbiology Saliva , by Region USD Million (2014-2019)
  • Table 23. Clinical Microbiology Others , by Region USD Million (2014-2019)
  • Table 24. Clinical Microbiology: by Product(USD Million)
  • Table 25. Clinical Microbiology Instrument , by Region USD Million (2014-2019)
  • Table 26. Clinical Microbiology Analyzer , by Region USD Million (2014-2019)
  • Table 27. Clinical Microbiology Reagent , by Region USD Million (2014-2019)
  • Table 28. South America Clinical Microbiology, by Country USD Million (2014-2019)
  • Table 29. South America Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 30. South America Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 31. South America Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 32. South America Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 33. South America Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 34. Brazil Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 35. Brazil Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 36. Brazil Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 37. Brazil Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 38. Brazil Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 39. Argentina Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 40. Argentina Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 41. Argentina Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 42. Argentina Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 43. Argentina Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 44. Rest of South America Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 45. Rest of South America Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 46. Rest of South America Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 47. Rest of South America Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 48. Rest of South America Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 49. Asia Pacific Clinical Microbiology, by Country USD Million (2014-2019)
  • Table 50. Asia Pacific Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 51. Asia Pacific Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 52. Asia Pacific Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 53. Asia Pacific Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 54. Asia Pacific Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 55. China Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 56. China Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 57. China Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 58. China Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 59. China Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 60. Japan Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 61. Japan Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 62. Japan Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 63. Japan Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 64. Japan Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 65. India Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 66. India Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 67. India Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 68. India Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 69. India Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 70. South Korea Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 71. South Korea Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 72. South Korea Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 73. South Korea Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 74. South Korea Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 75. Taiwan Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 76. Taiwan Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 77. Taiwan Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 78. Taiwan Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 79. Taiwan Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 80. Australia Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 81. Australia Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 82. Australia Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 83. Australia Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 84. Australia Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 85. Rest of Asia-Pacific Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 86. Rest of Asia-Pacific Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 87. Rest of Asia-Pacific Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 88. Rest of Asia-Pacific Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 89. Rest of Asia-Pacific Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 90. Europe Clinical Microbiology, by Country USD Million (2014-2019)
  • Table 91. Europe Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 92. Europe Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 93. Europe Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 94. Europe Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 95. Europe Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 96. Germany Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 97. Germany Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 98. Germany Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 99. Germany Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 100. Germany Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 101. France Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 102. France Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 103. France Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 104. France Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 105. France Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 106. Italy Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 107. Italy Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 108. Italy Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 109. Italy Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 110. Italy Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 111. United Kingdom Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 112. United Kingdom Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 113. United Kingdom Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 114. United Kingdom Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 115. United Kingdom Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 116. Netherlands Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 117. Netherlands Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 118. Netherlands Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 119. Netherlands Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 120. Netherlands Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 121. Rest of Europe Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 122. Rest of Europe Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 123. Rest of Europe Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 124. Rest of Europe Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 125. Rest of Europe Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 126. MEA Clinical Microbiology, by Country USD Million (2014-2019)
  • Table 127. MEA Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 128. MEA Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 129. MEA Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 130. MEA Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 131. MEA Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 132. Middle East Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 133. Middle East Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 134. Middle East Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 135. Middle East Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 136. Middle East Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 137. Africa Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 138. Africa Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 139. Africa Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 140. Africa Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 141. Africa Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 142. North America Clinical Microbiology, by Country USD Million (2014-2019)
  • Table 143. North America Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 144. North America Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 145. North America Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 146. North America Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 147. North America Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 148. United States Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 149. United States Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 150. United States Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 151. United States Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 152. United States Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 153. Canada Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 154. Canada Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 155. Canada Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 156. Canada Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 157. Canada Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 158. Mexico Clinical Microbiology, by Application USD Million (2014-2019)
  • Table 159. Mexico Clinical Microbiology, by End Users USD Million (2014-2019)
  • Table 160. Mexico Clinical Microbiology, by Disease USD Million (2014-2019)
  • Table 161. Mexico Clinical Microbiology, by Sample USD Million (2014-2019)
  • Table 162. Mexico Clinical Microbiology, by Product USD Million (2014-2019)
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Clinical Microbiology: by Application(USD Million)
  • Table 174. Clinical Microbiology Pharmaceutical , by Region USD Million (2020-2025)
  • Table 175. Clinical Microbiology Food Testing , by Region USD Million (2020-2025)
  • Table 176. Clinical Microbiology Energy , by Region USD Million (2020-2025)
  • Table 177. Clinical Microbiology Chemical and Material Manufacturing , by Region USD Million (2020-2025)
  • Table 178. Clinical Microbiology Environment , by Region USD Million (2020-2025)
  • Table 179. Clinical Microbiology: by End Users(USD Million)
  • Table 180. Clinical Microbiology Hospital , by Region USD Million (2020-2025)
  • Table 181. Clinical Microbiology Diagnolab , by Region USD Million (2020-2025)
  • Table 182. Clinical Microbiology Academia , by Region USD Million (2020-2025)
  • Table 183. Clinical Microbiology: by Disease(USD Million)
  • Table 184. Clinical Microbiology Respiratory Diseases , by Region USD Million (2020-2025)
  • Table 185. Clinical Microbiology Bloodstream Infections , by Region USD Million (2020-2025)
  • Table 186. Clinical Microbiology Gastrointestinal Diseases , by Region USD Million (2020-2025)
  • Table 187. Clinical Microbiology Sexually Transmitted Diseases , by Region USD Million (2020-2025)
  • Table 188. Clinical Microbiology Urinary Tract Infections , by Region USD Million (2020-2025)
  • Table 189. Clinical Microbiology Periodontal Diseases , by Region USD Million (2020-2025)
  • Table 190. Clinical Microbiology Other , by Region USD Million (2020-2025)
  • Table 191. Clinical Microbiology: by Sample(USD Million)
  • Table 192. Clinical Microbiology Urine , by Region USD Million (2020-2025)
  • Table 193. Clinical Microbiology Blood , by Region USD Million (2020-2025)
  • Table 194. Clinical Microbiology Saliva , by Region USD Million (2020-2025)
  • Table 195. Clinical Microbiology Others , by Region USD Million (2020-2025)
  • Table 196. Clinical Microbiology: by Product(USD Million)
  • Table 197. Clinical Microbiology Instrument , by Region USD Million (2020-2025)
  • Table 198. Clinical Microbiology Analyzer , by Region USD Million (2020-2025)
  • Table 199. Clinical Microbiology Reagent , by Region USD Million (2020-2025)
  • Table 200. South America Clinical Microbiology, by Country USD Million (2020-2025)
  • Table 201. South America Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 202. South America Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 203. South America Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 204. South America Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 205. South America Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 206. Brazil Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 207. Brazil Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 208. Brazil Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 209. Brazil Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 210. Brazil Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 211. Argentina Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 212. Argentina Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 213. Argentina Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 214. Argentina Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 215. Argentina Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 216. Rest of South America Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 217. Rest of South America Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 218. Rest of South America Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 219. Rest of South America Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 220. Rest of South America Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 221. Asia Pacific Clinical Microbiology, by Country USD Million (2020-2025)
  • Table 222. Asia Pacific Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 223. Asia Pacific Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 224. Asia Pacific Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 225. Asia Pacific Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 226. Asia Pacific Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 227. China Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 228. China Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 229. China Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 230. China Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 231. China Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 232. Japan Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 233. Japan Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 234. Japan Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 235. Japan Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 236. Japan Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 237. India Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 238. India Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 239. India Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 240. India Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 241. India Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 242. South Korea Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 243. South Korea Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 244. South Korea Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 245. South Korea Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 246. South Korea Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 247. Taiwan Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 248. Taiwan Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 249. Taiwan Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 250. Taiwan Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 251. Taiwan Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 252. Australia Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 253. Australia Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 254. Australia Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 255. Australia Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 256. Australia Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 257. Rest of Asia-Pacific Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 258. Rest of Asia-Pacific Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 259. Rest of Asia-Pacific Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 260. Rest of Asia-Pacific Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 261. Rest of Asia-Pacific Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 262. Europe Clinical Microbiology, by Country USD Million (2020-2025)
  • Table 263. Europe Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 264. Europe Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 265. Europe Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 266. Europe Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 267. Europe Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 268. Germany Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 269. Germany Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 270. Germany Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 271. Germany Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 272. Germany Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 273. France Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 274. France Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 275. France Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 276. France Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 277. France Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 278. Italy Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 279. Italy Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 280. Italy Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 281. Italy Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 282. Italy Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 283. United Kingdom Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 284. United Kingdom Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 285. United Kingdom Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 286. United Kingdom Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 287. United Kingdom Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 288. Netherlands Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 289. Netherlands Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 290. Netherlands Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 291. Netherlands Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 292. Netherlands Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 293. Rest of Europe Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 294. Rest of Europe Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 295. Rest of Europe Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 296. Rest of Europe Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 297. Rest of Europe Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 298. MEA Clinical Microbiology, by Country USD Million (2020-2025)
  • Table 299. MEA Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 300. MEA Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 301. MEA Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 302. MEA Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 303. MEA Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 304. Middle East Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 305. Middle East Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 306. Middle East Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 307. Middle East Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 308. Middle East Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 309. Africa Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 310. Africa Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 311. Africa Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 312. Africa Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 313. Africa Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 314. North America Clinical Microbiology, by Country USD Million (2020-2025)
  • Table 315. North America Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 316. North America Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 317. North America Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 318. North America Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 319. North America Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 320. United States Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 321. United States Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 322. United States Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 323. United States Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 324. United States Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 325. Canada Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 326. Canada Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 327. Canada Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 328. Canada Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 329. Canada Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 330. Mexico Clinical Microbiology, by Application USD Million (2020-2025)
  • Table 331. Mexico Clinical Microbiology, by End Users USD Million (2020-2025)
  • Table 332. Mexico Clinical Microbiology, by Disease USD Million (2020-2025)
  • Table 333. Mexico Clinical Microbiology, by Sample USD Million (2020-2025)
  • Table 334. Mexico Clinical Microbiology, by Product USD Million (2020-2025)
  • Table 335. Research Programs/Design for This Report
  • Table 336. Key Data Information from Secondary Sources
  • Table 337. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Microbiology: by Application USD Million (2014-2019)
  • Figure 5. Global Clinical Microbiology: by End Users USD Million (2014-2019)
  • Figure 6. Global Clinical Microbiology: by Disease USD Million (2014-2019)
  • Figure 7. Global Clinical Microbiology: by Sample USD Million (2014-2019)
  • Figure 8. Global Clinical Microbiology: by Product USD Million (2014-2019)
  • Figure 9. South America Clinical Microbiology Share (%), by Country
  • Figure 10. Asia Pacific Clinical Microbiology Share (%), by Country
  • Figure 11. Europe Clinical Microbiology Share (%), by Country
  • Figure 12. MEA Clinical Microbiology Share (%), by Country
  • Figure 13. North America Clinical Microbiology Share (%), by Country
  • Figure 14. Global Clinical Microbiology share by Players 2019 (%)
  • Figure 15. Global Clinical Microbiology share by Players (Top 3) 2019(%)
  • Figure 16. Global Clinical Microbiology share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 19. 3M (United States) Revenue: by Geography 2019
  • Figure 20. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Agilent Technologies Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Avantor (United States) Revenue, Net Income and Gross profit
  • Figure 23. Avantor (United States) Revenue: by Geography 2019
  • Figure 24. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 25. Becton Dickinson (United States) Revenue: by Geography 2019
  • Figure 26. Biomrieux SA (France) Revenue, Net Income and Gross profit
  • Figure 27. Biomrieux SA (France) Revenue: by Geography 2019
  • Figure 28. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 29. Bio-Rad Laboratories (United States) Revenue: by Geography 2019
  • Figure 30. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Danaher Corporation (United States) Revenue: by Geography 2019
  • Figure 32. NEOGEN Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. NEOGEN Corporation (United States) Revenue: by Geography 2019
  • Figure 34. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 35. Merck (United States) Revenue: by Geography 2019
  • Figure 36. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 37. Thermo Fisher Scientific (United States) Revenue: by Geography 2019
  • Figure 38. Global Clinical Microbiology: by Application USD Million (2020-2025)
  • Figure 39. Global Clinical Microbiology: by End Users USD Million (2020-2025)
  • Figure 40. Global Clinical Microbiology: by Disease USD Million (2020-2025)
  • Figure 41. Global Clinical Microbiology: by Sample USD Million (2020-2025)
  • Figure 42. Global Clinical Microbiology: by Product USD Million (2020-2025)
  • Figure 43. South America Clinical Microbiology Share (%), by Country
  • Figure 44. Asia Pacific Clinical Microbiology Share (%), by Country
  • Figure 45. Europe Clinical Microbiology Share (%), by Country
  • Figure 46. MEA Clinical Microbiology Share (%), by Country
  • Figure 47. North America Clinical Microbiology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • 3M (United States)
  • Agilent Technologies Inc. (United States)
  • Avantor (United States)
  • Becton Dickinson (United States)
  • Biomrieux SA (France)
  • Bio-Rad Laboratories (United States)
  • Danaher Corporation (United States)
  • NEOGEN Corporation (United States)
  • Merck (United States)
  • Thermo Fisher Scientific (United States)
Additional players considered in the study are as follows:
Hologic (United States) , Bruker (United States) , Roche Diagnostics (Switzerland)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation